This study examined how well a new artificial intelligence tool could detect prostate cancer compared to using just a PSA blood test. The AI system combined multiple MRI images and clinical data to make its assessments. It was tested on 305 patients who had already undergone MRI scans and biopsies to confirm their diagnosis.
The results showed that the AI tool performed significantly better than PSA alone. It correctly identified cancer in 85.3% of cases and correctly ruled it out in 90.9% of cases. The overall accuracy was 88.5%, which is much higher than the 59.2% accuracy of PSA testing by itself.
Because this was a retrospective study looking at past data, these promising results need to be confirmed in new, ongoing research. There were no reported safety issues with the imaging technology itself. Readers should understand that this is an early finding and not yet ready to change standard medical practice.